Tien Liang BioTech Co (ROCO:4127) Cyclically Adjusted Book per Share: NT$13.11 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4127 Tien Liang BioTech Co Ltd ROCO:4127
38 GF Score
Price NT$83.00
GF Value NT$39.17
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Tien Liang BioTech Co Cyclically Adjusted Book per Share?

Tien Liang BioTech Co ROCO:4127 +2.22% 38 Cyclically Adjusted Book per Share is NT$13.11 as of Dec. 2025. GuruFocus rates ROCO:4127 with a GF Score™ of 38/100 and a GF Value™ of NT$39.17 (Significantly Overvalued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Tien Liang BioTech Co's adjusted book value per share for the three months ended in Dec. 2025 was NT$10.359. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$13.11 for the trailing ten years ended in Dec. 2025.

During the past 12 months, Tien Liang BioTech Co's average Cyclically Adjusted Book Growth Rate was -7.50% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -5.80% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -3.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Tien Liang BioTech Co was -1.40% per year. The lowest was -5.80% per year. And the median was -2.50% per year.

As of today (2026-07-16), Tien Liang BioTech Co's current stock price is NT$83.00. Tien Liang BioTech Co's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2025 was NT$13.11. Tien Liang BioTech Co's Cyclically Adjusted PB Ratio of today is 6.33.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Tien Liang BioTech Co was 5.65. The lowest was 0.53. And the median was 0.93.


Tien Liang BioTech Co  (ROCO:4127) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Tien Liang BioTech Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=83.00/13.11
=6.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Tien Liang BioTech Co was 5.65. The lowest was 0.53. And the median was 0.93.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Tien Liang BioTech Co Cyclically Adjusted Book per Share Related Terms


Tien Liang BioTech Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Tien Liang BioTech Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tien Liang BioTech Co Cyclically Adjusted Book per Share Chart

Tien Liang BioTech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.77 15.69 15.03 14.18 13.11

Tien Liang BioTech Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.18 14.01 13.77 13.50 13.11

ROCO:4127 vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Tien Liang BioTech Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tien Liang BioTech Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tien Liang BioTech Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Tien Liang BioTech Co's Cyclically Adjusted PB Ratio falls into.


ROCO:4127
38GF Score
Tien Liang BioTech Co Ltd ROCO:4127
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tien Liang BioTech Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Tien Liang BioTech Co's adjusted Book Value per Share data for the three months ended in Dec. 2025 was:

Adj_Book= Book Value per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=10.359/324.0540*324.0540
=10.359

Current CPI (Dec. 2025) = 324.0540.

Tien Liang BioTech Co Quarterly Data

Book Value per Share CPI Adj_Book
201603 18.274 238.132 24.868
201606 17.776 241.018 23.900
201609 17.345 241.428 23.281
201612 16.721 241.432 22.443
201703 16.344 243.801 21.724
201706 10.865 244.955 14.373
201709 12.331 246.819 16.190
201712 12.156 246.524 15.979
201803 12.081 249.554 15.688
201806 11.687 251.989 15.029
201809 10.900 252.439 13.992
201812 10.184 251.233 13.136
201903 9.784 254.202 12.473
201906 9.434 256.143 11.935
201909 8.886 256.759 11.215
201912 9.161 256.974 11.552
202003 9.116 258.115 11.445
202006 8.722 257.797 10.964
202009 8.323 260.280 10.362
202012 8.026 260.474 9.985
202103 7.764 264.877 9.499
202106 8.025 271.696 9.571
202109 8.476 274.310 10.013
202112 9.048 278.802 10.517
202203 9.593 287.504 10.813
202206 9.812 296.311 10.731
202209 10.010 296.808 10.929
202212 10.383 296.797 11.337
202303 10.525 301.836 11.300
202306 10.644 305.109 11.305
202309 10.613 307.789 11.174
202312 10.773 306.746 11.381
202403 10.938 312.332 11.349
202406 10.362 314.175 10.688
202409 10.414 315.301 10.703
202412 10.444 315.605 10.724
202503 10.884 319.799 11.029
202506 9.843 322.561 9.889
202509 10.452 324.800 10.428
202512 10.359 324.054 10.359

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of NT$13.11 mean?
Tien Liang BioTech Co (ROCO:4127) has a Cyclically Adjusted Book per Share of NT$13.11 as of Dec. 2025. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Tien Liang BioTech Co and its competitors.
Is Tien Liang BioTech Co's Cyclically Adjusted Book per Share too high?
Tien Liang BioTech Co's current Cyclically Adjusted Book per Share is NT$13.11. Overall, Tien Liang BioTech Co has a GF Score™ of 38/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tien Liang BioTech Co's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Tien Liang BioTech Co's Cyclically Adjusted Book per Share of NT$13.11 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Tien Liang BioTech Co and its competitors. Tien Liang BioTech Co's current Cyclically Adjusted Book per Share is NT$13.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tien Liang BioTech Co stock overvalued right now?
Based on GuruFocus' analysis, Tien Liang BioTech Co (ROCO:4127) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$39.17, compared to a current price of NT$83.00 — trading 111.9% above its estimated fair value. The current Cyclically Adjusted Book per Share is NT$13.11. Tien Liang BioTech Co's overall GF Score™ is 38/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Tien Liang BioTech Co (ROCO:4127), the current Cyclically Adjusted Book per Share is NT$13.11 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tien Liang BioTech Co (ROCO:4127) Overvalued in 2026?

Based on GuruFocus' analysis, Tien Liang BioTech Co stock appears to be overvalued. The current stock price of NT$83.00 is trading 111.9% above its estimated GF Value™ of NT$39.17. GuruFocus considers Tien Liang BioTech Co to be Significantly Overvalued.

Key valuation signals for ROCO:4127:

  • Cyclically Adjusted Book per Share: NT$13.11
  • GF Value™: NT$39.17 vs. price of NT$83.00 (111.9% above fair value)
  • GF Score™: 38/100 with 8 warning signs

No single metric tells the full story. See the ROCO:4127 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Tien Liang BioTech Co Business Description

Address No. 147, Section 1, Datong Road, 9th Floor, Xizhi District, New Taipei City, TWN
Tien Liang BioTech Co Ltd develops and supplies chemicals, pharmaceutical, and Chinese herbs. It offers products for the treatment of intestinal track disease, osteoporosis, eye drops, cholesterin content, angiosclerosis, and hepatic diseases.
38GF Score

Get the complete analysis for ROCO:4127

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$83.00
Price
NT$39.17
GF Value